Share Price and Basic Stock Data
Last Updated: December 26, 2025, 11:47 pm
| PEG Ratio | -1.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Moongipa Capital Finance Ltd operates in the Non-Banking Financial Company (NBFC) sector, with a current market capitalization of ₹15.1 Cr and a share price of ₹16.5. Over recent quarters, the company’s sales have exhibited significant fluctuations. The revenue reported for June 2023 was ₹1.04 Cr, which surged to ₹2.62 Cr by September 2023, marking a notable increase. This upward trend continued into December 2023, with revenues reaching ₹2.76 Cr, and projected to rise further to ₹3.02 Cr in March 2024. However, the sales figures of ₹3.31 Cr for June 2024 and ₹2.32 Cr for September 2024 suggest potential volatility in revenue generation. Annual sales have also shown growth, rising from ₹1.83 Cr in FY 2023 to ₹9.25 Cr in FY 2024, indicating a robust growth trajectory. Despite these gains, the company recorded a trailing twelve months (TTM) revenue of ₹10.31 Cr, which reflects a mixed performance against the backdrop of historical figures.
Profitability and Efficiency Metrics
Moongipa Capital Finance Ltd reported a net profit of ₹1.34 Cr, translating to a return on equity (ROE) of 9.43% and a return on capital employed (ROCE) of 12.1%. The operating profit margin (OPM) stood at a strong 43.87%, showcasing effective cost management despite prior periods of negative margins. The company faced challenges in profitability during FY 2023, posting a net loss of ₹1.52 Cr, but rebounded with a net profit of ₹1.75 Cr in FY 2024. This recovery is reflected in the EPS, which increased from a negative ₹4.98 in FY 2023 to ₹1.90 in FY 2024. Efficiency metrics reveal a cash conversion cycle (CCC) of 481.53 days, indicating potential inefficiencies in operational processes. The interest coverage ratio (ICR) of 29.55x demonstrates strong capacity to meet interest obligations, positioning the firm favorably against sector norms where lower ratios often indicate financial strain.
Balance Sheet Strength and Financial Ratios
The balance sheet of Moongipa Capital Finance Ltd reveals total assets of ₹30.54 Cr as of March 2025, supported by equity capital of ₹9.16 Cr and reserves of ₹15.21 Cr. The company’s borrowings have increased to ₹7.45 Cr, with a debt-to-equity ratio of 0.30, reflecting a conservative leverage strategy. The book value per share has risen to ₹24.94, providing a reassuring buffer for shareholders. In terms of liquidity, the current ratio is reported at a robust 4.29x, indicating strong short-term financial health. Conversely, the quick ratio of 3.29x further suggests that the company is well-positioned to meet its immediate liabilities. Financial ratios such as P/BV at 0.77x and P/E at 11.3x indicate that the stock may be undervalued compared to peers in the NBFC sector, which typically hover around higher multiples, suggesting potential upside for investors.
Shareholding Pattern and Investor Confidence
Moongipa Capital Finance Ltd maintains a stable shareholding structure, with promoters holding 37.39% of the company, while public shareholders account for 62.61%. The number of shareholders has increased from 4,221 in December 2022 to 5,771 by September 2025, reflecting growing investor interest and confidence in the company’s prospects. The consistent promoter holding indicates a level of commitment and alignment with shareholder interests. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may raise questions about institutional confidence and broader market perceptions. The company’s ability to attract institutional investment could be pivotal for enhancing liquidity and valuation in the future. Overall, the shareholding pattern suggests a firm foundation of retail investor support, which could be beneficial for future capital raises.
Outlook, Risks, and Final Insight
Looking ahead, Moongipa Capital Finance Ltd is positioned for potential growth, primarily driven by its improving revenue and profitability metrics. However, risks remain, including operational inefficiencies indicated by the long cash conversion cycle and reliance on increasing borrowings, which could affect financial stability if not managed prudently. The company’s ability to sustain its growth trajectory will depend on effective cost management and operational improvements. The absence of significant institutional investment may also pose challenges in terms of market perception and stock liquidity. Nonetheless, with a solid balance sheet and a commitment to enhancing shareholder value, Moongipa Capital Finance Ltd could navigate these challenges effectively. Should the company manage to streamline its operations and attract institutional investors, it could realize substantial upside potential, presenting an attractive proposition in the NBFC space.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.8 Cr. | 1.48 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.63 Cr. | 0.76 | 8.62/0.75 | 22.4 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 462 Cr. | 63.4 | 127/59.1 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.1 Cr. | 16.5 | 34.4/15.0 | 11.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 37.1 Cr. | 82.5 | 162/74.8 | 19.8 | 238 | 1.21 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,751.38 Cr | 462.33 | 53.30 | 522.46 | 0.22% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.73 | 0.45 | 0.60 | 0.27 | 1.04 | 2.62 | 2.76 | 3.02 | 3.31 | 2.32 | 2.16 | 1.10 | 3.10 |
| Expenses | 2.69 | 0.16 | 0.52 | 1.02 | 0.58 | 1.98 | 2.07 | 3.17 | 2.05 | 1.72 | 1.79 | 1.44 | 1.74 |
| Operating Profit | -1.96 | 0.29 | 0.08 | -0.75 | 0.46 | 0.64 | 0.69 | -0.15 | 1.26 | 0.60 | 0.37 | -0.34 | 1.36 |
| OPM % | -268.49% | 64.44% | 13.33% | -277.78% | 44.23% | 24.43% | 25.00% | -4.97% | 38.07% | 25.86% | 17.13% | -30.91% | 43.87% |
| Other Income | 0.02 | 0.00 | 0.03 | 0.12 | 0.08 | 0.12 | 0.06 | 0.11 | 0.06 | 0.10 | 0.07 | 0.11 | 0.05 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.17 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Profit before tax | -1.96 | 0.27 | 0.09 | -0.65 | 0.53 | 0.74 | 0.73 | -0.06 | 1.31 | 0.69 | 0.43 | -0.31 | 1.22 |
| Tax % | -38.78% | 14.81% | 11.11% | -4.62% | 9.43% | 12.16% | 19.18% | -133.33% | 22.90% | 18.84% | 18.60% | 70.97% | 22.95% |
| Net Profit | -1.21 | 0.22 | 0.08 | -0.62 | 0.48 | 0.65 | 0.59 | 0.02 | 1.01 | 0.56 | 0.35 | -0.53 | 0.95 |
| EPS in Rs | -1.32 | 0.24 | 0.09 | -0.67 | 0.52 | 0.71 | 0.64 | 0.02 | 1.10 | 0.61 | 0.38 | -0.58 | 1.04 |
Last Updated: August 19, 2025, 1:00 pm
Below is a detailed analysis of the quarterly data for Moongipa Capital Finance Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3.10 Cr.. The value appears strong and on an upward trend. It has increased from 1.10 Cr. (Mar 2025) to 3.10 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Jun 2025, the value is 1.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.44 Cr. (Mar 2025) to 1.74 Cr., marking an increase of 0.30 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from -0.34 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 1.70 Cr..
- For OPM %, as of Jun 2025, the value is 43.87%. The value appears strong and on an upward trend. It has increased from -30.91% (Mar 2025) to 43.87%, marking an increase of 74.78%.
- For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.17 Cr., marking an increase of 0.10 Cr..
- For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.22 Cr.. The value appears strong and on an upward trend. It has increased from -0.31 Cr. (Mar 2025) to 1.22 Cr., marking an increase of 1.53 Cr..
- For Tax %, as of Jun 2025, the value is 22.95%. The value appears to be improving (decreasing) as expected. It has decreased from 70.97% (Mar 2025) to 22.95%, marking a decrease of 48.02%.
- For Net Profit, as of Jun 2025, the value is 0.95 Cr.. The value appears strong and on an upward trend. It has increased from -0.53 Cr. (Mar 2025) to 0.95 Cr., marking an increase of 1.48 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.04. The value appears strong and on an upward trend. It has increased from -0.58 (Mar 2025) to 1.04, marking an increase of 1.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.54 | 0.66 | 0.64 | 1.11 | 1.06 | 0.88 | 0.59 | 1.24 | 3.70 | 1.83 | 9.25 | 8.78 | 10.31 |
| Expenses | 0.53 | 0.57 | 0.78 | 0.65 | 0.56 | 1.55 | 1.16 | 0.42 | 0.61 | 4.14 | 7.61 | 6.85 | 8.09 |
| Operating Profit | 0.01 | 0.09 | -0.14 | 0.46 | 0.50 | -0.67 | -0.57 | 0.82 | 3.09 | -2.31 | 1.64 | 1.93 | 2.22 |
| OPM % | 1.85% | 13.64% | -21.88% | 41.44% | 47.17% | -76.14% | -96.61% | 66.13% | 83.51% | -126.23% | 17.73% | 21.98% | 21.53% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.15 | 0.37 | 0.31 | 0.31 |
| Interest | 0.03 | 0.02 | 0.00 | 0.00 | 0.03 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | 0.08 | 0.40 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.08 | 0.06 | 0.05 | 0.06 |
| Profit before tax | -0.04 | 0.05 | -0.16 | 0.80 | 0.45 | -0.72 | -0.60 | 0.82 | 3.02 | -2.25 | 1.95 | 2.11 | 2.07 |
| Tax % | 25.00% | 60.00% | 0.00% | 10.00% | 20.00% | -22.22% | 0.00% | 48.78% | 18.87% | -32.89% | 10.26% | 35.07% | |
| Net Profit | -0.05 | 0.02 | -0.16 | 0.71 | 0.36 | -0.55 | -0.60 | 0.42 | 2.45 | -1.52 | 1.75 | 1.38 | 1.34 |
| EPS in Rs | -0.05 | 0.02 | -0.17 | 0.77 | 0.39 | -0.60 | -0.65 | 0.46 | 2.66 | -1.65 | 1.90 | 1.51 | 1.46 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 140.00% | -900.00% | 543.75% | -49.30% | -252.78% | -9.09% | 170.00% | 483.33% | -162.04% | 215.13% | -21.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1040.00% | 1443.75% | -593.05% | -203.48% | 243.69% | 179.09% | 313.33% | -645.37% | 377.17% | -236.27% |
Moongipa Capital Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 72% |
| 3 Years: | 33% |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 34% |
| 3 Years: | -17% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 62% |
| 3 Years: | 9% |
| 1 Year: | -42% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 6% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 9.16 | 9.16 |
| Reserves | 0.50 | 0.51 | 0.35 | 1.06 | 1.42 | 0.87 | 0.26 | 0.68 | 3.13 | 1.61 | 3.35 | 13.70 | 15.21 |
| Borrowings | 0.26 | 0.05 | 0.40 | 0.25 | 0.61 | 0.31 | 0.31 | 0.00 | 0.00 | 0.12 | 0.00 | 7.01 | 7.45 |
| Other Liabilities | 0.04 | 0.03 | 0.02 | 0.08 | 0.03 | 0.06 | 0.05 | 0.21 | 0.78 | 0.06 | 0.20 | 0.67 | 0.82 |
| Total Liabilities | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 | 32.64 |
| Fixed Assets | 0.07 | 0.04 | 0.07 | 0.05 | 0.04 | 0.03 | 0.07 | 0.05 | 0.31 | 0.23 | 0.18 | 0.13 | 0.20 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.88 | 0.93 | 1.33 | 1.47 | 1.65 | 0.96 | 1.60 | 2.58 | 5.34 | 2.64 | 1.43 | 6.85 | 6.57 |
| Other Assets | 2.90 | 2.67 | 2.42 | 2.92 | 3.42 | 3.30 | 2.00 | 1.31 | 1.31 | 1.97 | 4.99 | 23.56 | 25.87 |
| Total Assets | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 | 32.64 |
Below is a detailed analysis of the balance sheet data for Moongipa Capital Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.16 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.16 Cr..
- For Reserves, as of Sep 2025, the value is 15.21 Cr.. The value appears strong and on an upward trend. It has increased from 13.70 Cr. (Mar 2025) to 15.21 Cr., marking an increase of 1.51 Cr..
- For Borrowings, as of Sep 2025, the value is 7.45 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 7.01 Cr. (Mar 2025) to 7.45 Cr., marking an increase of 0.44 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.67 Cr. (Mar 2025) to 0.82 Cr., marking an increase of 0.15 Cr..
- For Total Liabilities, as of Sep 2025, the value is 32.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.54 Cr. (Mar 2025) to 32.64 Cr., marking an increase of 2.10 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.07 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 6.57 Cr.. The value appears to be declining and may need further review. It has decreased from 6.85 Cr. (Mar 2025) to 6.57 Cr., marking a decrease of 0.28 Cr..
- For Other Assets, as of Sep 2025, the value is 25.87 Cr.. The value appears strong and on an upward trend. It has increased from 23.56 Cr. (Mar 2025) to 25.87 Cr., marking an increase of 2.31 Cr..
- For Total Assets, as of Sep 2025, the value is 32.64 Cr.. The value appears strong and on an upward trend. It has increased from 30.54 Cr. (Mar 2025) to 32.64 Cr., marking an increase of 2.10 Cr..
Notably, the Reserves (15.21 Cr.) exceed the Borrowings (7.45 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.25 | 0.04 | -0.54 | 0.21 | -0.11 | -0.98 | -0.88 | 0.82 | 3.09 | -2.43 | 1.64 | -5.08 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.96 | 7.10 | 50.72 |
| Inventory Days | 463.06 | 199.54 | 430.81 | |||||||||
| Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 477.02 | 206.64 | 481.53 |
| Working Capital Days | 919.26 | 1,227.73 | 39.92 | 62.48 | 134.29 | 825.40 | 532.03 | 158.95 | 53.27 | 295.19 | 177.96 | 875.92 |
| ROCE % | -0.26% | 1.89% | -4.32% | 19.61% | 10.17% | -14.61% | -15.03% | 22.59% | 60.95% | -40.88% | 34.88% | 12.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
| Diluted EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
| Cash EPS (Rs.) | 1.55 | 5.91 | -4.71 | 8.23 | 1.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
| Revenue From Operations / Share (Rs.) | 9.56 | 30.28 | 5.98 | 10.45 | 3.22 |
| PBDIT / Share (Rs.) | 2.44 | 6.59 | -7.09 | 10.11 | 2.78 |
| PBIT / Share (Rs.) | 2.39 | 6.38 | -7.36 | 9.89 | 2.71 |
| PBT / Share (Rs.) | 2.30 | 6.38 | -7.39 | 9.88 | 2.68 |
| Net Profit / Share (Rs.) | 1.50 | 5.71 | -4.98 | 8.01 | 1.36 |
| PBDIT Margin (%) | 25.52 | 21.75 | -118.56 | 96.75 | 86.25 |
| PBIT Margin (%) | 24.96 | 21.08 | -123.04 | 94.61 | 84.15 |
| PBT Margin (%) | 24.10 | 21.07 | -123.44 | 94.55 | 83.13 |
| Net Profit Margin (%) | 15.71 | 18.86 | -83.15 | 76.61 | 42.29 |
| Return on Networth / Equity (%) | 6.02 | 27.23 | -32.61 | 39.56 | 11.14 |
| Return on Capital Employeed (%) | 9.32 | 29.77 | -48.15 | 43.60 | 21.19 |
| Return On Assets (%) | 4.50 | 26.44 | -31.41 | 35.12 | 10.56 |
| Total Debt / Equity (X) | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.47 | 1.62 | 0.30 | 0.58 | 0.25 |
| Current Ratio (X) | 4.29 | 137.98 | 27.37 | 189.17 | 118.77 |
| Quick Ratio (X) | 3.29 | 59.81 | 22.32 | 189.17 | 118.77 |
| Inventory Turnover Ratio (X) | 1.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 29.55 | 1770.36 | -298.50 | 1674.16 | 83.93 |
| Interest Coverage Ratio (Post Tax) (X) | 19.19 | 1536.47 | -208.36 | 1326.56 | 42.16 |
| Enterprise Value (Cr.) | 24.69 | 8.89 | 5.21 | 6.73 | 0.91 |
| EV / Net Operating Revenue (X) | 2.82 | 0.96 | 2.85 | 2.11 | 0.92 |
| EV / EBITDA (X) | 11.04 | 4.42 | -2.40 | 2.18 | 1.08 |
| MarketCap / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
| Price / BV (X) | 0.77 | 1.40 | 1.12 | 1.11 | 0.28 |
| Price / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
| EarningsYield | 0.07 | 0.19 | -0.29 | 0.35 | 0.39 |
After reviewing the key financial ratios for Moongipa Capital Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 3. It has decreased from 5.91 (Mar 24) to 1.55, marking a decrease of 4.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.56. It has decreased from 30.28 (Mar 24) to 9.56, marking a decrease of 20.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 2.44, marking a decrease of 4.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.39, marking a decrease of 3.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.30, marking a decrease of 4.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 2. It has decreased from 5.71 (Mar 24) to 1.50, marking a decrease of 4.21.
- For PBDIT Margin (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from 21.75 (Mar 24) to 25.52, marking an increase of 3.77.
- For PBIT Margin (%), as of Mar 25, the value is 24.96. This value exceeds the healthy maximum of 20. It has increased from 21.08 (Mar 24) to 24.96, marking an increase of 3.88.
- For PBT Margin (%), as of Mar 25, the value is 24.10. This value is within the healthy range. It has increased from 21.07 (Mar 24) to 24.10, marking an increase of 3.03.
- For Net Profit Margin (%), as of Mar 25, the value is 15.71. This value exceeds the healthy maximum of 10. It has decreased from 18.86 (Mar 24) to 15.71, marking a decrease of 3.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 15. It has decreased from 27.23 (Mar 24) to 6.02, marking a decrease of 21.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.32. This value is below the healthy minimum of 10. It has decreased from 29.77 (Mar 24) to 9.32, marking a decrease of 20.45.
- For Return On Assets (%), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. It has decreased from 26.44 (Mar 24) to 4.50, marking a decrease of 21.94.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.30, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 1.62 (Mar 24) to 0.47, marking a decrease of 1.15.
- For Current Ratio (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 137.98 (Mar 24) to 4.29, marking a decrease of 133.69.
- For Quick Ratio (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 2. It has decreased from 59.81 (Mar 24) to 3.29, marking a decrease of 56.52.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 1.64, marking an increase of 1.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 29.55. This value is within the healthy range. It has decreased from 1,770.36 (Mar 24) to 29.55, marking a decrease of 1,740.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.19. This value is within the healthy range. It has decreased from 1,536.47 (Mar 24) to 19.19, marking a decrease of 1,517.28.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.69. It has increased from 8.89 (Mar 24) to 24.69, marking an increase of 15.80.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.82, marking an increase of 1.86.
- For EV / EBITDA (X), as of Mar 25, the value is 11.04. This value is within the healthy range. It has increased from 4.42 (Mar 24) to 11.04, marking an increase of 6.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For Price / BV (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.77, marking a decrease of 0.63.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.19 (Mar 24) to 0.07, marking a decrease of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Moongipa Capital Finance Ltd:
- Net Profit Margin: 15.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.32% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.02% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 19.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.3 (Industry average Stock P/E: 53.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.3
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 18/14, W.E.A. Pusa Lane, Karol Bagh, New Delhi Delhi 110005 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr.(Ms.) Pooja Jain | Whole Time Director |
| Mr. Sanjay Jain | Non Executive Director |
| Mr. Ajay Prakash Narain | Independent Director |
| Mr. Rajesh Kumar | Independent Director |
FAQ
What is the intrinsic value of Moongipa Capital Finance Ltd?
Moongipa Capital Finance Ltd's intrinsic value (as of 29 December 2025) is 23.13 which is 40.18% higher the current market price of 16.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 15.1 Cr. market cap, FY2025-2026 high/low of 34.4/15.0, reserves of ₹15.21 Cr, and liabilities of 32.64 Cr.
What is the Market Cap of Moongipa Capital Finance Ltd?
The Market Cap of Moongipa Capital Finance Ltd is 15.1 Cr..
What is the current Stock Price of Moongipa Capital Finance Ltd as on 29 December 2025?
The current stock price of Moongipa Capital Finance Ltd as on 29 December 2025 is 16.5.
What is the High / Low of Moongipa Capital Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Moongipa Capital Finance Ltd stocks is 34.4/15.0.
What is the Stock P/E of Moongipa Capital Finance Ltd?
The Stock P/E of Moongipa Capital Finance Ltd is 11.3.
What is the Book Value of Moongipa Capital Finance Ltd?
The Book Value of Moongipa Capital Finance Ltd is 26.6.
What is the Dividend Yield of Moongipa Capital Finance Ltd?
The Dividend Yield of Moongipa Capital Finance Ltd is 0.00 %.
What is the ROCE of Moongipa Capital Finance Ltd?
The ROCE of Moongipa Capital Finance Ltd is 12.1 %.
What is the ROE of Moongipa Capital Finance Ltd?
The ROE of Moongipa Capital Finance Ltd is 9.43 %.
What is the Face Value of Moongipa Capital Finance Ltd?
The Face Value of Moongipa Capital Finance Ltd is 10.0.